Does Direct-to-Consumer Advertising of Antidepressants Lead to a Net Social Benefit?
As the access to this document is restricted, you may want to look for a different version under “Related research” (further below) or search for a different version of it. Publisher InfoArticle provided by Wolters Kluwer Health | Adis in its journal PharmacoEconomics. Volume (Year): 26 (2008) Issue (Month): 7 () Pages: 557-566 Download reference. The following formats are available: HTML (with abstract), plain text (with abstract), BibTeX, RIS (EndNote, RefMan, ProCite), ReDIF Handle: RePEc:wkh:phecon:v:26:y:2008:i:7:p:557-566 Contact details of provider: Web page: http://pharmacoeconomics.adisonline.com/ For technical questions regarding this item, or to correct its listing, contact: liame2(‘com’,’wolterskluwer’,’m7i7′,’Bouckaert’,’Remco’) (Remco Bouckaert). Related researchKeywords: Advertising; Antidepressants; Cost-benefit; Cost-utility; Depression; Prescribing; Resource-use; Find related papers by JEL classification: C – Mathematical and Quantitative Methods D – Microeconomics I
